Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

SHA:688273 Revenue

Nanjing Medlander Medical Technology had revenue of 102.09M CNY in the quarter ending September 30, 2026, a decrease of -0.52%. This brings the company's total for the last twelve months to 382.77M, down -12.57% year-over-year. In the year 2025, Nanjing Medlander Medical Technology had annual revenue of 431.59M with 1.66% growth. That makes Nanjing Medlander Medical Technology the 26,944th largest company in the world by revenue and 4,707th in China.

• Revenue (ttm): 382.77M
• Revenue Growth: -12.57%
• P/S Ratio: 6.61
• Revenue / Employee: 684.74K
• Employees: 559
• Market Cap: 2.53B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pelvic Floor Rehabilitation 160.01M 38.1%
• Reproductive Rehabilitation 127.11M 30.3%
• Consumables and Accessories 122.31M 29.1%
• Sports Rehabilitation 8.76M 2.1%
• Other Products 1.64M 0.4%

By Geography

Chart

• China 417.33M 99.4%
• Overseas 2.49M 0.6%

Fiscal year ended Dec 31, 2025 See the full SHA:688273 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	431.59M	7.04M	1.66%
Dec 31, 2024	424.55M	83.72M	24.57%
Dec 31, 2023	340.82M	-36.06M	-9.57%
Dec 31, 2022	376.89M	35.25M	10.32%
Dec 31, 2021	341.64M	5.12M	1.52%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error